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We have developed a simple and sensitive method for the detection of influenza A virus
based on giant magnetoresistance (GMR) biosensor. This assay employs monoclonal
antibodies to viral nucleoprotein (NP) in combination with magnetic nanoparticles
(MNPs). Presence of influenza virus allows the binding of MNPs to the GMR sensor
and the binding is proportional to the concentration of virus. Binding of MNPs onto the
GMR sensor causes change in the resistance of sensor, which is measured in a real
time electrical readout. GMR biosensor detected as low as 1.5 × 102 TCID50/mL virus
and the signal intensity increased with increasing concentration of virus up to 1.0 × 105
TCID50/mL. This study showed that the GMR biosensor assay is relevant for diagnostic
application since the virus concentration in nasal samples of influenza virus infected
swine was reported to be in the range of 103 to 105 TCID50/mL.
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INTRODUCTION
Influenza viruses belong to the family Orthomyxoviridae, which are enveloped single strand
negative sense RNA viruses with segmented RNA genome. Based on their matrix (M) and
nucleoprotein (NP), influenza viruses are classified into type A, B, or C. Influenza A viruses (IAVs)
are further classified into subtypes based on their surface glycoproteins, hemagglutinin (HA),
and neuraminidase (NA). IAV is a common respiratory pathogen infecting many hosts including
humans, pigs (swine influenza virus or SIV) and birds (avian influenza virus or AIV). In addition
to SIV, pigs are susceptible to infection with influenza viruses of human and avian origin and this
is believed to contribute to novel reassortant influenza viruses with pandemic potential (Kida et al.,
1994). Surveillance of swine and avian influenza viruses in the wild, in farms, and in live bird
markets is critical for detection of newly emerging influenza viruses with significant impact on
human and veterinary public health. Rapid, sensitive, and reliable method for detection of IAV in
the environment, tissues and body fluids is important for controlling the infection and reducing
the impact of possible influenza pandemic by early detection and rapid intervention. Currently,
laboratory diagnosis of IAV relies on isolation of virus in embryonated chicken eggs or cell culture,
detection of viral antigens, serological tests to detect virus specific antibodies, and detection of viral
RNA by reverse transcription-quantitative polymerase chain reaction (RT-qPCR; Lee et al., 1993;
Townsend et al., 2006; Leuwerke et al., 2008; Chen et al., 2011). Virus isolation is sensitive method
and considered gold standard for virus diagnosis (Amano and Cheng, 2005), however, this labor
intensive technique requires average of 3–7 days to obtain the results (Ellis and Zambon, 2002).
Detection of viral antigens and serological test for antibody detection are either poor in specificity
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or low in sensitivity. Although, RT-qPCR is highly sensitive
and specific method, its requirement for expensive laboratory
instruments and technical expertise (Ellis and Zambon, 2002;
Payungporn et al., 2006) in addition to longer time for the
completion of the test, as it involves RNA extraction step, limits
its application in the field. The objective of this study is to
develop sensitive and specific method for detection of swine
influenza viruses with minimum sample handling and laboratory
skill requirements.
Various technologies have been developed for rapid, sensitive,
and specific detection of virus using nanotechnology-based
approaches (Lee et al., 2011; Nidzworski et al., 2014). These
technologies use nanoparticles in combination with electrical or
electrochemical detection (Patolsky et al., 2004; Tam et al., 2009;
Shirale et al., 2010; Driskell et al., 2011; Li et al., 2011; Singh
et al., 2014). To date, chip-based giant magnetoresistance (GMR)
spin valves along with magnetic nanoparticles (MNPs) have
become a powerful tool for high sensitivity, real-time electrical
readout, and rapid biomolecule detection (Baselt et al., 1998; Rife
et al., 2003; Graham et al., 2004; Schotter et al., 2004; Millen
et al., 2005; Loureiro et al., 2009, 2011; Gaster et al., 2011;
Wang et al., 2014). The fabrication and integration of GMR
biosensors are compatible with the large multiplex technology
and the current Very Large Scale Integration (VLSI) technology
(Wang et al., 2015) so it is possible to lower down the cost if
the mass production is carried out. Moreover, GMR chips can
be integrated with not only electronics but also microfluidics
for immunoassay applications (Xu et al., 2008; Zhi et al., 2012).
In addition, GMR biosensors are matrix-insensitive (Zhang and
Zhou, 2012) and therefore their performance are very robust
and not affected by environmental factors such as temperature
and pH.
Giant magnetoresistance-based immunoassay detection is
based on the principle that stray field from MNPs that bound
on sensor surface will alter the magnetization in free layer
(Supplementary Figure S1), thus changing the resistance of
GMR sensors (Baibich et al., 1988; Binasch et al., 1989).
A higher number of MNPs bound to GMR sensors per unit
area leads to a higher detection signal. GMR sensors have
been utilized previously in biomolecule and chemical detection
(Srinivasan et al., 2009, 2011; Zhi et al., 2012). Unlike fluorescent
labels used in immunofluorescence methods, MNPs do not
bleach (Eickenberg et al., 2013). In addition, there is no
ferromagnetism property in biological samples, allowing the
detection of magnetic signals with less background noise (Zhang
et al., 2013). Nowadays, the size of MNPs can be controlled to
the identical size as the biomolecules to which they will interact
with (Hsing et al., 2007). Furthermore, labeling large molecules
as well as nano- or micro-particles with small biomolecules can
be successfully realized (Hsing et al., 2007; Ladj et al., 2013; Zhou
et al., 2015).
In the present study, we demonstrated sensitive detection of
influenza virus using GMR biosensors. The virus type specific
broadly reactive monoclonal antibodies to NP employed in this
study were able to detect IAV of swine and human origin in direct
antigen capture enzyme linked immunosorbent assay (ELISA).
Using swine influenza virus H3N2v as a representative virus
we found the limit of detection of GMR biosensor assay was
1.5 × 102 TCID50/mL virus. Comparison of GMR biosensor-
based detection with antigen capture ELISA showed that GMR
biosensor was more sensitive. In addition, GMR biosensor-
based assay allows for a real time measurement of signals.
The signals are captured and processed immediately as it is




The human pandemic influenza A/California/04/2009 (H1N1
CA/09), the swine influenza viruses A/Sw/Iowa/73 (H1N1
IA/73), A/Sw/Illinois/2008 (H1N1 IL/08), and A (H3N2) variant
virus (H3N2v) were obtained from the University of Minnesota
Veterinary Diagnostic Laboratory (St Paul, MN). Viruses
were propagated in Madin-Darby canine kidney (MDCK)
cells (ATCC CCL-34) in Dulbecco’s modified Eagle medium
(DMEM) containing 0.5 µg/mL TPCK-trypsin (Worthington
Biochemical Corporation, Lakewood, NJ, USA) and purified
from the clarified cell culture supernatants by ultracentrifugation
through a 30% (w/v) sucrose cushion and stored in aliquots
at −80◦C. Culture supernatant from un-infected MDCK cells
were processed similarly to use for mock virus preparation. The
concentration of purified virus was determined by TCID50 assay.
For immunoassays the virus was inactivated at 60◦C for 1 h. To
disrupt the virus particles, the mock and virus preparation were
treated with 1% IGEPAL CA-630 (Sigma-Aldrich, Product No.
I8896) for 10 min at 37◦C.
GMR Chip Fabrication and Sensor Array
Structure
The multilayer GMR spin valve films with top–down structure
of Ta (50 Å)/NiFe (20 Å)/CoFe(10 Å)/Cu(33 Å)/CoFe(25 Å)/
IrMn(80 Å)/Ta (25 Å) were deposited by a Shamrock Magnetron
Sputter System onto Si/SiO2 (1000 Å) substrate at the University
of Minnesota. A 4-inch GMR wafer containing 21 usable chips
is manufactured by photolithography, ion beam milling, and
electron beam evaporation techniques. An 18 nm thick Al2O3
layer was coated onto chip surface by atomic layer deposition
(ALD) followed by a 20 nm SiO2 layer by plasma-enhanced
chemical vapor deposition (PECVD) in order to prevent current
leakage and in the meanwhile SiO2 layer paves the way for future
surface functionalization.
Each GMR chip is in the size of 16 mm × 16 mm with
8 × 8 sensor array in its center (Figures 1A,B). Each sensor
is in the size of 120 µm × 120 µm containing five GMR strip
groups connected in series and each group contains 10 GMR
strips connected in parallel (Figure 1C). Each strip with the size
of 120 µm × 750 nm is separated by 2 µm (Figure 1D). All the
GMR chips were annealed at 200◦C under an applied magnetic
field of 0.5 Tesla along the minor axis (Figure 1C) for 1 h then
naturally cooled down to room temperature in order to fully align
the magnetization in the pinned layer.
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FIGURE 1 | Fabricated giant magnetoresistance (GMR) chip. (A) GMR




Giant magnetoresistance chips are first exposed to ultraviolet
light and ozone (UVO) for 15 min to remove organic material
from the sensor surface as well as to expose the hydroxyl
group bonding sites. Each chip is then soaked in 5 mL
anhydrous toluene mixed with 1% of 3-aminopropyltriethoxy
silane (APTES) for 1 h at room temperature to allow APTES to
covalently bind to the hydroxyl group (Figure 2A) from silica
layer that is on-top-of GMR biosensors. Chips are thoroughly
rinsed with acetone followed by ethanol and dried with nitrogen
gas. The surface of APTES modified chips contain amino groups.
To attach aldehyde groups onto sensor surface, the 64-sensor-
array area of each chip is covered with 5% glutaraldehyde (Glu)
solution (100 µL) and incubated at room temperature for 5 h
under a relative humidity of ∼97%. The terminal aldehyde
groups generated on the sensor surface allow subsequent covalent
bonding of biomolecules containing amino groups onto GMR
sensor (Wang et al., 2013, 2014, 2015).
Influenza A Virus Immunoassay
3-Aminopropyltriethoxysilane–Glu modified GMR sensors were
robotically printed with 500 µg/mL influenza A capture antibody
(MAB8800; EMD Millipore Corporation, Temecula, CA, USA,
specific to IAV NP) in a volume of 1.2 nL per sensor using
the sci-FLEXARRAYER S5 (Scienion, Germany; Supplementary
Figure S2). For the control reactions bovine serum albumin
(BSA; 1 mg/mL) and biotinylated bovine serum albumin (biotin-
BSA; 1 mg/mL) were similarly printed onto GMR sensors.
The 8 × 8 sensor array were divided into three regions
(Supplementary Figure S2). Four columns (32 sensors) were
spotted with influenza A capture antibody, two columns (16
sensors) with biotin-BSA, and the rest two columns (16 sensors)
with BSA. Printed chips were incubated at 4◦C for 12 h under
a relative humidity of ∼97%. A bottomless reaction well made
of polymethyl methacrylate (PMMA) was attached onto chip
centered at the sensor area. This reaction well can hold as
much as 100 µL liquid. Next, the sensor area was rinsed with
PBST [0.05% tween 20 in phosphate buffered saline (PBS)] for
three cycles to remove unbound biomolecules. To block any
potential binding sites on the sensor, 100 µL of 10 mg/mL
BSA was added to the reaction well and incubated at room
temperature for 30 min. After removing BSA and washing the
sensor area with 100 µL of PBST for three cycles, 100 µL of
antigen (heat inactivated virus) of different concentrations were
added to the reaction well and incubated at room temperature
for 1 h. After washing the sensor area with 100 µL of PBST for
three cycles, 100 µL of 5 µg/mL biotinylated detection antibody
(MAB8257B, EMD Millipore Corporation, Temecula, CA, USA,
a mouse anti influenza A monoclonal antibody specific for NP)
was added and incubated at room temperature for another 1 h.
Subsequently, detection antibody was aspirated and sensor area
was rinsed with PBST for three cycles. Chips were kept at 4◦C,
97% humidity condition before real-time testing. In order to
detect all IAV subtypes, the capture and detection antibodies
specific to influenza A NP were used. These antibodies were
certified by the manufacturer as influenza A specific and the
detection antibody was not shown to cross react with influenza
B or other respiratory viruses.
Detection Principle and Signal Flow
A sandwich assay structure (Srinivasan et al., 2009, 2011) used
in this study is illustrated in Figure 2B. The detailed detection
architecture is shown in Figure 2C. First, capture antibody
was immobilized on the GMR sensor, then the antigen and
biotinylated detection antibody were added successively and
allowed to bind. Finally, streptavidin labeled MNPs (Miltenyi
Biotec, Inc., Auburn, CA, USA; Catalog No. 130-048-101)
were added and specifically bound to the near surface of
sensor through the biotin-streptavidin interaction. Number of
bound MNPs is proportional to number of target antigen. It is
worthwhile to mention that, since there are 64 sensors in one
GMR chip, it is possible to detect 64 types of biomolecules in one
test.
In a bench top system, a probe station with 17 × 4 pin array
(Supplementary Figure S2) is connected to the pads of GMR chip
(Wang et al., 2015). An alternating current with frequency of
1000 Hz flows through the main bus. An in-plane magnetic field
with amplitude of 30 Oe, frequency of 50 Hz is applied along the
minor axis direction. A Digital Acquisition card (DAQ, NI USB-
6289, 18-Bit, 625 kS/s) collects analog signals from side tones at
950 and 1050 Hz and carries out fast Fourier transform (FFT)
before sending the data points back. It takes 1 s to collect one data
points on one sensor, since there are 64 sensors in one GMR chip;
it takes 1 min to go through all the sensors. Signals are extracted
from the background noise using a Wheatstone bridge and then
amplified by low-noise, low-distortion instrumentation amplifier
(INA163, Texas Instruments).
Enzyme Linked Immunosorbent Assay
Microtiter plates (Corning, Inc., Corning, NY, USA) were coated
with 100 µL of 3 µg/mL anti-influenza A monoclonal antibody
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FIGURE 2 | Schematic representation of GMR biosensor. (A) Schematic diagram of GMR biosensor surface functionalization. (B) Schematic drawing of a
typical sandwich structure; (C) Schematic illustration of influenza A virus detection.
(MAB8800; EMD Millipore Corporation, Temecula, CA, USA)
specific for influenza A NP. After overnight incubation at 4◦C,
the wells were blocked with 5% skim milk in PBS for 2 h at room
temperature. 100 µL of heat inactivated virus diluted in sample
diluent (3% BSA in PBS) was then added and incubated for 1 h
at 37◦C. After washing the wells three times with wash buffer
(0.05% tween 20 in PBS), 100 µL of 1 µg/mL biotinylated anti-
influenza A monoclonal antibody (MAB8257B; EMD Millipore
Corporation, Temecula, CA, USA) was added and incubated for
1 h at room temperature. Wells were washed three times with
wash buffer and incubated for 30 min at room temperature with
100 µL of 1:1000 diluted Pierce high sensitivity streptavidin-
horseradish peroxidase (HRP; Thermo scientific, Rockford, IL,
USA). After washing the wells three times with wash buffer,
100 µL of one step ultra TMB (Thermo scientific, Rockford,
IL, USA) was added and the reaction was stopped after 30 min
incubation at room temperature by adding 100µL of 1 N H2SO4.
The absorbance at 450 nm was measured by microtiter plate
reader (Thermo Scientific). The cut off value was calculated as
mean of negative control multiplied by 2.
RESULTS
To validate the IAV specific antibodies to use in GMR biosensor
assay, we performed antigen capture ELISA using human or
swine isolates of IAV. All the IAV strains tested showed positive
result by ELISA (Figure 3) suggesting that these antibodies are
capable of detecting multiple IAV strains.
FIGURE 3 | Direct antigen capture ELISA for influenza virus detection
using human and swine isolates of IAV. 100 µl of 1:100 dilution of the
virus (1.0 × 103 TCID50/mL) were added to the wells for testing. Mock: no
virus. Dotted line indicates the cut off value. Error bars represent SEM.
The real-time binding curves for influenza biosensor are
shown in Figure 4A. Initially 30µL of PBS was preloaded into the
reaction well. After 15 min of stabilization, 30 µL MNP solution
was added into reaction and signals were collected for another
35 min. Signals from reactions with different concentrations of
virus increased immediately after addition of MNP solution,
which indicates a real-time binding of MNPs onto GMR sensors.
Furthermore, the signal increased with increasing concentration
of virus. The averaged signal from 1.5 × 102 TCID50/mL viruses
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FIGURE 4 | Giant magnetoresistance biosensor showed higher sensitivity than ELISA for detection of IAV. Swine IAV strain H3N2v or control (mock) were
treated with 1% IGEPAL CA-630 to disrupt virus particle and used for detection by GMR biosensor and ELISA. (A) Binding curves in real-time on GMR biosensor;
(B) Signals averaged over the last 10 data points from different concentrations of IAV and negative control (mock) in GMR biosensor and; (C) Antigen capture ELISA
with different concentrations of IAV. Dotted line indicates the cut off value. Error bars represent SEM.
FIGURE 5 | Field-emission gun scanning electron microscopy (FEG-SEM) images of MNPs bound onto GMR sensors after test. (A) Biotin-BSA positive
control; (B) 1.0 × 104 TCID50/mL virus; (C) 1.0 × 103 TCID50/mL virus; (D) 2.0 × 102 TCID50/mL virus; (E) BSA negative control.
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is 5.45 µV, and it goes up with increased virus concentration and
reaches to 94.1 µV for 1.0 × 105 TCID50/mL virus (Figure 4B).
The signal from negative control group did not show any obvious
rise and the averaged signal was 2.2 µV, indicating that the
signals are specific to IAV. The cut-off value for distinguishing
positive from negative was set as 3.0 µV, since the mean value
of negative control plus three times standard deviation of the
mean is 3.0. As the signal from 1.0 × 102 TCID50/mL viruses
was below 3.0 µV (1.52 ± 0.37 µV), the detection limit of GMR
sensor was estimated as 1.5 × 102 TCID50/mL. We compared
GMR biosensor assay for influenza virus with antigen capture
ELISA and found that the GMR biosensor was more sensitive
than ELISA. The limit of detection of antigen capture ELISA
using these monoclonal antibodies was 2.5 × 102 TCID50/mL
(Figure 4C).
To further confirm the binding of MNPs to the GMR sensor,
these chips were investigated by field-emission gun scanning
electron microscopy (FEG-SEM) at the Characterization Facility,
University of Minnesota. The GMR chips were rinsed with DI
water to wash away unbound MNPs and dried by nitrogen gas.
The chips were then coated with 50 Å of Platinum (Pt) and
observed by FEG-SEM. As shown in Figure 5, number of bound
MNPs per unit area increases as the concentration of influenza
virus increases.
DISCUSSION
This work extends the application of GMR-based assay for virus
detection. In this study, a sensitive GMR biosensor was developed
for the detection of influenza virus. We selected viral NP as
target antigen to detect all strains of IAV, since large scale
sequence analysis of this viral protein showed high degree of
conservation among different subtypes of IAV from multiple
hosts and lineages (Kukol and Hughes, 2014). As NP is localized
within the virus particle, a non-ionic, non-denaturing detergent
IGEPAL CA-630 was used to disrupt the virus particles in the
sample. The results demonstrated that the GMR biosensor is able
to detect viral concentrations ranging from 1.5× 102 to 1.0× 105
TCID50/mL. This is relevant to nasal samples of infected swine,
which has been reported to contain 103 to 105 TCID50/mL viral
particles (Lekcharoensuk et al., 2006). In addition, our results
showed that the GMR biosensor is more sensitive than ELISA.
Therefore, GMR biosensor assay has a potential for diagnosis and
monitoring of influenza virus. In this study, we used purified
virus diluted in buffer for the assay. Further work is required
to address the effect of sample matrix on the sensitivity and
specificity of GMR sensor. Although, detection antibody was
not reported to cross react with influenza B or other respiratory
viruses, further validation of GMR biosensor using these related
viruses as well as multiple strains of swine influenza viruses are
needed to assess the practical application of this technique.
Although, IAV H3N2v was used as a representative influenza
virus in our GMR biosensor system, this assay can be further
extended to other viruses and infectious agents. Since there
are 64 sensor arrays in one GMR chip, this assay can be
further optimized to detect different subtypes of influenza viruses
in a single test or simultaneously detect different pathogens
from single sample. The assay is simple with minimum sample
preparation, although GMR biosensor surface functionalization
and antibody immobilization on the sensor requires time and
labor. Protein incubation, sample handling and washing could
be improved by integrating with the well-developed microfluidic
channel platform. In addition, it is possible to integrate this assay
into portable, hand held device for on-site application.
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